Tag: investment
-
Infographic – Health Care A.I. Funds Jump in Q1
Venture funding for start-ups providing artificial intelligence services in health care climbed to a record high volume in the first quarter of 2021.
-
New Biotech Creating Precision Cancer Therapies
A biotechnology company began work in public to develop new treatments that target proteins responsible for gene expression, beginning with cancer.
-
Early-Stage Life Science Investment Fund Raises $515M
A new venture investment fund raised $515 million for life science start-ups, and its business incubator partner added five biotechs to its seed round portfolio.
-
Synthetic Bio Company Goes Public in $2.5B Merger
A company developing synthetic biology and engineering tools for biotechnology is becoming a public company through a special-purpose acquisition.
-
New Biotech Developing Synthetic Long-Term RNA
A new enterprise, created by a life science venture capital company, began work on developing therapies with long-acting synthetic RNA.
-
AI Gene Therapy Platform Gains $100M in Early Funds
A company using machine learning to create engineered viruses to deliver gene therapies is raising $100 million in its first venture funding round.
-
Cell Therapy Mfring Company Raises $82M in Venture Funds
A company developing an automated yet personalized manufacturing platform for cell therapies is raising $82 million in its second venture funding round.
-
Biomanufacturing Materials Company Issues $500M IPO
Zymergen Inc., a developer of materials made with synthetic biology for industrial products is raising $500 million in its initial public stock offering.
-
Microbiome Health Company Raises $40M in Early Funds
A developer of therapies and health products addressing microbes inhabiting the human body is raising $40 million in its first venture funding round.
-
Start-Up Designing Synthetic DNA for Gene Therapies
A new biotechnology company is underway creating gene therapies for inherited diseases delivered with synthetic DNA instead of benign viruses.